European patent protection for medical uses of known products and drug repurposing

Mateo Aboy^*, Kathleen Liddell, Matthew Jordan, Cristina Crespo, Johnathon Liddicoat

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

6 Citations (Scopus)

18 Downloads (Pure)

Abstract

Obtaining European patent protection for medical uses of known products is not a key factor limiting
repurposing activity.

@article{1d3d585a28a4476183a66f52cb2e37bd,

title = "European patent protection for medical uses of known products and drug repurposing",

abstract = "Obtaining European patent protection for medical uses of known products is not a key factor limitingrepurposing activity.",

author = "Mateo Aboy and Kathleen Liddell and Matthew Jordan and Cristina Crespo and Johnathon Liddicoat",

year = "2022",

doi = "10.1038/s41587-022-01269-3",

language = "English",

volume = "40",

pages = "465",

journal = "Nature Biotechnology",

issn = "1087-0156",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - European patent protection for medical uses of known products and drug repurposing

AU - Aboy, Mateo

AU - Liddell, Kathleen

AU - Jordan, Matthew

AU - Crespo, Cristina

AU - Liddicoat, Johnathon

PY - 2022

Y1 - 2022

N2 - Obtaining European patent protection for medical uses of known products is not a key factor limitingrepurposing activity.

AB - Obtaining European patent protection for medical uses of known products is not a key factor limitingrepurposing activity.

U2 - 10.1038/s41587-022-01269-3

DO - 10.1038/s41587-022-01269-3

M3 - Article

SN - 1087-0156

VL - 40

SP - 465

JO - Nature Biotechnology

JF - Nature Biotechnology

ER -